Description
IGF-1 LR3 is a recombinant, modified form of insulin-like growth factor 1 with lowered binding-protein affinity and a longer activity window. Researchers use it as an IGF-1 receptor agonist in growth-factor studies.
In cultured cells and laboratory animals, investigations have focused on receptor signaling, cell proliferation and differentiation, protein-synthesis pathways, and metabolic markers. Its extended activity makes it a practical probe for growth-factor research.
Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.






Reviews
There are no reviews yet.